Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan ; volume:10 ; number:1 ; day:11 ; month:1 ; year:2010 ; pages:1-11 ; date:12.2010
BMC health services research ; 10, Heft 1 (11.1.2010), 1-11, 12.2010
- Creator
-
Liu, Pang-Hsiang
- Contributor
-
Hu, Fu-Chang
Lee, Ping-Ing
Chow, Song-Nan
Huang, Chao-Wan
Wang, Jung-Der
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-10-11
- URN
-
urn:nbn:de:1111-2016072131107
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Pang-Hsiang
- Hu, Fu-Chang
- Lee, Ping-Ing
- Chow, Song-Nan
- Huang, Chao-Wan
- Wang, Jung-Der
- SpringerLink (Online service)
Other Objects (12)
Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
Cost-effectiveness of human papillomavirus vaccination in Germany
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
Cost-effectiveness of human papillomavirus vaccination in Germany
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
Cost-effectiveness of human papillomavirus vaccination in Germany
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand